Literature DB >> 7489178

Prognostic factors in surgery for local recurrence of rectal cancer.

G Gagliardi1, P R Hawley, M J Hershman, S J Arnott.   

Abstract

Fifty-five patients had resection of locally recurrent rectal cancer. Fourteen patients (25 per cent) had distant metastases, which were resected concurrently in six (11 per cent). Thirty-three patients (60 per cent) had preoperative (one patient) or postoperative (32) external beam radiotherapy (45-60 Gy). The 5-year survival rate was 18 per cent with a median survival of 24 months. The median symptom-free interval was 24 months. At a median follow-up of 28 months 53 per cent of patients had a second local recurrence and 24 per cent metastases only. Treatment complications occurred in 12 patients (22 per cent), three (5 per cent) of whom died 3-10 months after operation. Variables that were significantly related with longer survival and palliation were the radical nature of the operation, the absence of severe symptoms (such as pain, obstruction or sepsis), a recurrent tumour diameter of less than 5 cm measured on the resected specimen and a normal carcinoembryonic antigen level after reoperation. A Cox regression model showed that recurrent tumour diameter was the only independent prognostic variable. Surgery for local recurrence achieved local control in 47 per cent of patients with a low morbidity and mortality rate.

Entities:  

Mesh:

Year:  1995        PMID: 7489178     DOI: 10.1002/bjs.1800821035

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

Review 1.  Multidisciplinary management in rectal cancer.

Authors:  Asunción Hervás Morón; María Luisa García de Paredes; Eduardo Lobo Martínez
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

2.  Reresection for local recurrence of rectal cancer.

Authors:  W Adachi; A Nishio; H Watanabe; J Igarashi; K Yazawa; Y Nimura; N Koide; A Matsushita; T Monma; K Hanazaki; S Kajikawa; J Amano
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  Clinicopathological features of anastomotic recurrence after an anterior resection for rectal cancer.

Authors:  Kenji Matsuda; Tsukasa Hotta; Katsunari Takifuji; Shozo Yokoyama; Yoshimasa Oku; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2009-06-10       Impact factor: 3.445

4.  Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.

Authors:  F Selvaggi; C Fucini; G Pellino; G Sciaudone; I Maretto; I Mondi; N Bartolini; F Caminati; S Pucciarelli
Journal:  Tech Coloproctol       Date:  2014-11-11       Impact factor: 3.781

5.  Predictors of successful salvage surgery for local pelvic recurrence of rectosigmoid colon and rectal cancers.

Authors:  Akihiko Kobayashi; Masanori Sugito; Masaaki Ito; Norio Saito
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

6.  Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection.

Authors:  Jea-Kun Park; Young-Wan Kim; Hyuk Hur; Nam-Kyu Kim; Byung-Soh Min; Seung-Kook Sohn; Young-Deuk Choi; Young-Tae Kim; Jung-Bai Ahn; Jae-Kyung Roh; Ki-Chang Keum; Jin-Sil Seong
Journal:  Langenbecks Arch Surg       Date:  2008-07-29       Impact factor: 3.445

Review 7.  Intentionally curative treatment of locally recurrent rectal cancer: a systematic review.

Authors:  Pieter J Tanis; Annemiek Doeksen; J Jan B van Lanschot
Journal:  Can J Surg       Date:  2013-04       Impact factor: 2.089

8.  Clinical application of CT-guided (125)I seed interstitial implantation for local recurrent rectal carcinoma.

Authors:  Zhongmin Wang; Jian Lu; Lin Liu; Tao Liu; Kemin Chen; Fenju Liu; Gang Huang
Journal:  Radiat Oncol       Date:  2011-10-18       Impact factor: 3.481

Review 9.  Advances in surgical management for locally recurrent rectal cancer: How far have we come?

Authors:  Daniel Jin-Keat Lee; Peter M Sagar; Gaitri Sadadcharam; Kok-Yang Tan
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.